Medicare Enrolled

Dr. Alberto Rotsztain, M.D.

Cardiovascular Disease · Naples, FL
Practice pattern: Cardiac & Cardiac— Practice combining cardiac and cardiac services
Low-engagement
1735 SW HEALTH PKWY STE 201, Naples, FL 34109
2392497800
In practice since 2006 (19 years)
NPI: 1619912193 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rotsztain from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rotsztain? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rotsztain

Dr. Alberto Rotsztain is a cardiovascular disease in Naples, FL, with 19 years in practice. Based on federal Medicare data, Dr. Rotsztain performed 644 Medicare services across 643 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rotsztain received a total of $7,735 from 30 pharmaceutical and/or device companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rotsztain is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 644 Medicare services$ $7,735 industry payments

Medicare Practice Summary

Medicare Utilization ↗
644
Medicare services
Bottom 17% in FL for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
643
Unique beneficiaries
$139
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~34 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Echocardiogram, transthoracic524$145$401
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report72$175$474
Heart muscle strain imaging37$28$76
Heart rhythm review and interpretation of continous external ekg over 8-15 days11$19$53
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
81.4% high complexity
16.9% medium
1.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,735
Total received (2018-2024)
Avg $1,105/year across 7 years
Top 30% in FL for cardiovascular disease
30
Companies
269
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,633 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$102 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$417
2023
$364
2022
$106
2021
$247
2020
$525
2019
$3,021
2018
$3,054

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,472
Amgen Inc.
$977
Merck Sharp & Dohme Corporation
$616
Novo Nordisk Inc
$595
Amarin Pharma Inc.
$508
Lilly USA, LLC
$393
AstraZeneca Pharmaceuticals LP
$380
Boehringer Ingelheim Pharmaceuticals, Inc.
$360
PFIZER INC.
$264
Abbott Laboratories
$262
GlaxoSmithKline, LLC.
$258
Regeneron Healthcare Solutions, Inc.
$240
Novartis Pharmaceuticals Corporation
$223
Kowa Pharmaceuticals America, Inc.
$203
Edwards Lifesciences Corporation
$137
Genentech USA, Inc.
$131
SANOFI-AVENTIS U.S. LLC
$131
Actelion Pharmaceuticals US, Inc.
$120
Sumitomo Pharma America, Inc.
$98
Astellas Pharma US Inc
$81
Merck Sharp & Dohme LLC
$69
Avanir Pharmaceuticals, Inc.
$53
Sanofi Pasteur Inc.
$37
AbbVie, Inc.
$25
SANOFI PASTEUR INC.
$24
Exact Sciences Corporation
$18
IDORSIA PHARMACEUTICALS US INC
$17
Allergan Inc.
$16
Seqirus USA Inc
$14
Radius Health, Inc.
$14
Top 3 companies account for 39.6% of total payments
Associated products mentioned in payments ›
Aimovig · BASAGLAR · BELSOMRA · BREZTRI · CAPVAXIVE · CHANTIX · Cologuard Collection Kit · Creon · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FREESTYLE LIBRE 3 · Fluad · GEMTESA · INVOKANA · JANUVIA · JARDIANCE · Lipofen · Livalo · MOUNJARO · MitraClip System · NUEDEXTA · OPSUMIT · Otezla · Ozempic · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · Prolia · QUVIVIQ · RENFLEXIS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tymlos · VESICARE · VIAGRA · VRAYLAR · Vascepa · XARELTO · Xofluza · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,201 per 100 Medicare services performed
Looking for a cardiovascular disease in Naples?
Compare cardiovascular diseases in the Naples area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
101
Per 100K population
26.1
County median income
$86,173
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
3.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rotsztain is a cardiac & cardiac specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rotsztain experienced with echocardiogram, transthoracic?
Based on Medicare claims data, Dr. Rotsztain performed 524 echocardiogram, transthoracic services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rotsztain receive payments from pharmaceutical companies?
Yes. Dr. Rotsztain received a total of $7,735 from 30 companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rotsztain's costs compare to other cardiovascular diseases in Naples?
Dr. Rotsztain's average Medicare payment per service is $139. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rotsztain) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →